GILEAD SCIENCES, INC. is 126.9x more valuable than Immatics N.V. by market capitalization ($151.05 B vs $1.19 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IMTX | GILD |
|---|---|---|
| Market cap | $1.19 B | $151.05 B |
| US-listed rank | #2511 | #99 |
| Revenue (latest FY) | - | $29.44B |
| Net income (latest FY) | - | $8.51B |
| Net margin | - | 28.9% |
| P/E (trailing FY) | - | 17.7 |
| SEC filings | 220 | 981 |
GILEAD SCIENCES, INC. is 126.9x more valuable than Immatics N.V. by market capitalization ($151.05 B vs $1.19 B).
Full pages: Immatics N.V. and GILEAD SCIENCES, INC., or browse the full rankings.